Send in the decoys: Cell-like particles ameliorate inflammatory autoimmune arthritis

2018 ◽  
Vol 10 (459) ◽  
pp. eaav0341
Author(s):  
Ankur Singh

Neutrophil membrane–coated nanoparticles reduce symptoms of rheumatoid arthritis in mice.

Nano Letters ◽  
2018 ◽  
Vol 19 (1) ◽  
pp. 124-134 ◽  
Author(s):  
Ruixiang Li ◽  
Yuwei He ◽  
Ying Zhu ◽  
Lixian Jiang ◽  
Shuya Zhang ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-9 ◽  
Author(s):  
Alexander A. Andreev-Andrievskiy ◽  
Nataliya G. Kolosova ◽  
Natalia A. Stefanova ◽  
Maxim V. Lovat ◽  
Maxim V. Egorov ◽  
...  

Rheumatoid arthritis is one of the most common autoimmune diseases. Many antioxidants have been tested in arthritis, but their efficacy was, at best, marginal. In this study, a novel mitochondria-targeted antioxidant, plastoquinonyl-decyl-triphenylphosphonium bromide (SkQ1), was testedin vivoto prevent and cure experimental autoimmune arthritis. In conventional Wistar rats, SkQ1 completely prevented the development of clinical signs of arthritis if administered with food before induction. Further, SkQ1 significantly reduced the fraction of animals that developed clinical signs of arthritis and severity of pathological lesions if administration began immediately after induction of arthritis or at the onset of first symptoms (day 14 after induction). In specific pathogen-free Wistar rats, SkQ1 administered via gavage after induction of arthritis did not reduce the fraction of animals with arthritis but decreased the severity of lesions upon pathology examination in a dose-dependent manner. Efficacious doses of SkQ1 were in the range of 0.25–1.25 nmol/kg/day (0.13–0.7 μg/kg/day), which is much lower than doses commonly used for conventional antioxidants. SkQ1 promoted apoptosis of neutrophilsin vitro, which may be one of the mechanisms underlying its pharmacological activity. Considering its low toxicity and the wide therapeutic window, SkQ1 may be a valuable additional therapy for rheumatoid arthritis.


PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0148486 ◽  
Author(s):  
Tue Wenzel Kragstrup ◽  
Babak Jalilian ◽  
Kresten Krarup Keller ◽  
Xianwei Zhang ◽  
Julie Kristine Laustsen ◽  
...  

2013 ◽  
Vol 190 (4) ◽  
pp. 1457-1465 ◽  
Author(s):  
Kristen N. Cordova ◽  
Van C. Willis ◽  
Kathryn Haskins ◽  
V. Michael Holers

2017 ◽  
Vol 18 (2) ◽  
pp. 109-109 ◽  
Author(s):  
A O Guerreiro-Cacais ◽  
◽  
U Norin ◽  
A Gyllenberg ◽  
R Berglund ◽  
...  

2018 ◽  
Author(s):  
Judith F. Ashouri ◽  
Lih-Yun Hsu ◽  
Steven Yu ◽  
Dmitry Rychkov ◽  
Yiling Chen ◽  
...  

AbstractHow pathogenic CD4 T cells in Rheumatoid Arthritis (RA) develop remains poorly understood. We used Nur77—a marker of T cell antigen receptor (TCR) signaling—to identify antigen-activated CD4 T cells in the SKG mouse model of autoimmune arthritis and in patients with RA. Using a fluorescent reporter of Nur77 expression in SKG mice, we found that higher levels of Nur77-eGFP in SKG CD4 T cells marked their autoreactivity, arthritogenic potential, and ability to more readily differentiate into IL-17 producing cells. The T cells with increased autoreactivity, nonetheless had diminished ex vivo inducible TCR signaling, perhaps reflective of adaptive inhibitory mechanisms induced by chronic auto-antigen exposure in vivo. The enhanced autoreactivity was associated with upregulation of IL-6 cytokine signaling machinery, which might in part be attributable to a reduced amount of expression of suppressor of cytokine signaling 3 (SOCS3)—a key negative regulator of IL-6 signaling. As a result, the more autoreactive GFPhi CD4 T cells from SKGNur mice were hyper-responsive to IL-6 receptor signaling. Consistent with findings from SKGNur mice, SOCS3 expression was similarly downregulated in RA synovium. This suggests that, despite impaired TCR signaling, autoreactive T cells exposed to chronic antigen stimulation exhibit heightened sensitivity to IL-6 which contributes to the arthritogenicity in SKG mice, and perhaps in patients with RA.Significance StatementHow arthritis-causing T cells trigger rheumatoid arthritis (RA) is not understood since it is difficult to differentiate T cells activated by inflammation in arthritic joints from those activated through their TCR by self-antigens. We developed a model to identify and study antigen-specific T cell responses in arthritis. Nur77—a specific marker of TCR signaling—was used to identify antigen-activated CD4 T cells in the SKG arthritis model and patients with RA. Nur77 could distinguish highly arthritogenic and autoreactive T cells in SKG mice. The enhanced autoreactivity was associated with increased IL-6-receptor-signaling, likely contributing to their arthritogenicity. These data highlight a functional correlate between Nur77 expression, arthritogenic T cell populations, and heightened IL-6 sensitivity in SKG mice with translatable implications for human RA.


Sign in / Sign up

Export Citation Format

Share Document